1945 Phase III HannaH study of subcutaneous or intravenous trastuzumab for HER2-positive early breast cancer: Exploratory subgroup analyses of pathological complete response and 3-year event-free survival according to body weight and anti-drug antibody status

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2015-09, Vol.51, p.S313-S314
Main Authors: Jackisch, C, Hegg, R, Stroyakovskiy, D, Ahn, J.S, Melichar, B, Chen, S.C, Crepelle-Fléchais, A, Lauer, S, Shing, M, Pivot, X
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(16)30893-0